Stay updated on Pemigatinib Dose-Escalation Clinical Trial

Sign up to get notified when there's something new on the Pemigatinib Dose-Escalation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pemigatinib Dose-Escalation Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T11:46:00.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Gastric cancer was added to the list of conditions for the study. The page revision was updated from v3.4.1 to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-12T15:55:22.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision: v3.4.1 replaces v3.4.0 on the page, a minor version update that does not affect study content or navigation. No substantive study information changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T12:16:07.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Added: Show glossary, 'Last Update Submitted that Met QC Criteria', No FEAR Act Data, and Revision: v3.4.0; Deleted: 'Last Update Submitted that met QC Criteria' (lowercase met), No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-29T07:28:13.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Revision: v3.3.4 added; previous v3.3.3 removed; no visible content or functionality changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T02:45:52.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    Locations were added for AL, CA, CT, DC, FL, GA, MI, MO, NJ, NY, NC, OH, SC, and TX; the HHS Vulnerability Disclosure link was removed.
    Difference
    0.9%
    Check dated 2025-12-24T13:51:53.000Z thumbnail image

Stay in the know with updates to Pemigatinib Dose-Escalation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pemigatinib Dose-Escalation Clinical Trial page.